Sc. Baraban et al., RESPIRATORY CONTROL OF SYMPATHETIC-NERVE ACTIVITY DURING NALOXONE-PRECIPITATED MORPHINE-WITHDRAWAL IN RATS, The Journal of pharmacology and experimental therapeutics, 265(1), 1993, pp. 89-95
In this study, we describe and compare the changes in phrenic nerve di
scharge and vasomotor sympathetic output produced by 1) acute administ
ration of morphine in naive rats and 2) naloxone-precipitated withdraw
al in morphine-dependent rats. Lumbar or splanchnic sympathetic nerve
discharge and phrenic nerve discharge were recorded along with mean ar
terial pressure and end-expiratory CO2 in vagotomized, urethane-anesth
etized, paralyzed and artificially ventilated rats. Acute injection of
morphine (1 and 5 mg/kg, i.v.) reduced resting mean arterial pressure
, resting phrenic nerve discharge amplitude, the sympathetic barorefle
x and the central respiratory drive of sympathetic nerve discharge. Su
bsequent administration of naloxone (1 mg/kg) reversed all cardiorespi
ratory effects of morphine and produced an overshoot, suggesting acute
withdrawal. Morphine-dependent rats displayed a prolonged central ins
piratory phase and a higher threshold for apnea. Naloxone-induced with
drawal was associated with an increase of mean arterial pressure and p
hrenic nerve discharge amplitude and a large reduction in the inspirat
ory phase. Withdrawal produced three distinct effects on sympathetic n
erve discharge: 1) sensitization of the baroreflex, 2) large increase
in the central respiratory drive and 3) selective increase in a respir
atory-independent component of the splanchnic sympathetic outflow. It
is concluded that the increase in central respiratory drive is a signi
ficant component of the sympathoactivation associated with naloxone-in
duced withdrawal.